17 / 182
REGULATORY
AUTHORITIES &
GOVERNMENT
Compliance
“Alignment and partnerships with regulatory
authorities and government are being consolidated“
HOW DO WE CREATE VALUE FOR
THE REGULATORY AUTHORITIES
AND GOVERNMENT
HOW DO WE ENGAGE WITH THE
REGULATORY AUTHORITIES AND
GOVERNMENT
HOW DO OUR OPERATIONS
AFFECT THE REGULATORY
AUTHORITIES AND GOVERNMENT
WHAT ARE THE ASSOCIATED RISKS
AND OPPORTUNITIES FOR US AND
THE REGULATORY AUTHORITIES
AND GOVERNMENT
WHAT ARE ASSOCIATED STRATEGIC
OBJECTIVES FOR ENSURING THAT
THE REGULATORY AUTHORITIES AND
GOVERNMENT’S NEEDS ARE MET
By continuing to
comply with the
relevant legislation
and regulations in an effort to provide South Africans
with quality, affordable medicines; participate in a visible,
viable and sustainable local pharmaceutical industry;
service government as a customer of our products.
Proactive government
relations engagement
strategy
is in place at executive and Board level
with key government ministers and officials in national,
provincial and local government. Regular contact,
including personal visits to regulatory bodies, particularly
the MCC. Also, through membership of the Chemical
Industries Education and Training Authority (CHIETA).
Efficiency of supply
promotes
accessibility and affordability of medicines; support
investment in South Africa, as well as empowerment,
transformation and corporate social investment initiatives.
The industry-specific
annual adjudication of
the single exit price
as increases have failed to cover the cost of increases
faced by the industry. The complex and ever-evolving
regulatory environment provides challenges with product
registrations, which are common throughout the industry.
Through continuous
monitoring,
a rigid approach to quality
control and assurance, compliance is continuously
achieved through the ongoing combined efforts of
various teams.
FIVE
SIX
THREE
ONE
FOUR
TWO
CREATING VALUE FOR OUR STAKEHOLDERS
(continued)
| 13
Integrated Report 2016